ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,702, issued on Nov. 4, was assigned to NATIONAL TAIWAN UNIVERSITY (Taipei, Taiwan).
"Conjugate for targeting therapy" was invented by Pi-Hui Liang (Taipei, Taiwan), Chun-Kai Chang (Tuku Township, Taiwan) and Pei-Fang Chiu (Tainan, Taiwan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a novel conjugate or a pharmaceutically acceptable salt thereof, wherein the conjugate has an active pharmaceutical moiety or a prodrug thereof, a targeting module and a linker therebetween. The conjugate or a pharmaceutically acceptable salt thereof is useful for treating a disease, recurrence or progression in a subject or increasing the...